Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barry J Goldstein

Showing results (41-50 of 75) with videos related to

Pageof 8
Sort By:
Cardiovascular Diabetology|January 5, 2013
Cardiovascular safety of sitagliptin in patients with type 2 diabetes mellitus: a pooled analysisSamuel S Engel, Gregory T Golm, Deborah Shapiro, et al.
Metabolism: Clinical and Experimental|June 12, 2003
Protein-tyrosine phosphatase activity in human adipocytes is strongly correlated with insulin-stimulated glucose uptake and is a target of insulin-induced oxidative inhibitionXiangdong Wu, V Elise Hardy, Jeffrey I Joseph, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|February 25, 2015
Erratum to: Comparison of Treatment with Sitagliptin or Sulfonylurea in Patients with Type 2 Diabetes Mellitus and Mild Renal Impairment: A Post Hoc Analysis of Clinical TrialsElizabeth S Ommen, Lei Xu, Edward A O'Neill, et al.
Drugs & Aging|February 11, 2014
Safety of sitagliptin in elderly patients with type 2 diabetes: a pooled analysis of 25 clinical studiesElizabeth M Round, Samuel S Engel, Gregory T Golm, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|June 13, 2013
Assessment of AACE/ACE recommendations for initial dual antihyperglycemic therapy using the fixed-dose combination of sitagliptin and metformin versus metforminSamuel S Engel, Thomas L Seck, Gregory T Golm, et al.
The Journal of Clinical Investigation|June 6, 2007
Adiponectin deficiency increases leukocyte-endothelium interactions via upregulation of endothelial cell adhesion molecules in vivoRaogo Ouedraogo, Yulan Gong, Brett Berzins, et al.
Hepatology Communications|February 7, 2018
Clinical endpoints and adaptive clinical trials in precirrhotic nonalcoholic steatohepatitis: Facilitating development approaches for an emerging epidemicClaudia Filozof, Shein-Chung Chow, Lara Dimick-Santos, et al.
Molecular and Cellular Biology|February 18, 2004
The NAD(P)H oxidase homolog Nox4 modulates insulin-stimulated generation of H2O2 and plays an integral role in insulin signal transductionKalyankar Mahadev, Hiroyuki Motoshima, Xiangdong Wu, et al.
Alternative Therapies in Health and Medicine|September 29, 2007
Mindfulness-based stress reduction is associated with improved glycemic control in type 2 diabetes mellitus: a pilot studySteven Rosenzweig, Diane K Reibel, Jeffrey M Greeson, et al.
Diabetes|May 30, 2006
Adiponectin suppression of high-glucose-induced reactive oxygen species in vascular endothelial cells: evidence for involvement of a cAMP signaling pathwayRaogo Ouedraogo, Xiangdong Wu, Shi-Qiong Xu, et al.
Pageof 8

Showing results (41-50 of 75) with videos related to

Sort By:
Pageof 8
Cardiovascular Diabetology|January 5, 2013
Cardiovascular safety of sitagliptin in patients with type 2 diabetes mellitus: a pooled analysisSamuel S Engel, Gregory T Golm, Deborah Shapiro, et al.
Metabolism: Clinical and Experimental|June 12, 2003
Protein-tyrosine phosphatase activity in human adipocytes is strongly correlated with insulin-stimulated glucose uptake and is a target of insulin-induced oxidative inhibitionXiangdong Wu, V Elise Hardy, Jeffrey I Joseph, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|February 25, 2015
Erratum to: Comparison of Treatment with Sitagliptin or Sulfonylurea in Patients with Type 2 Diabetes Mellitus and Mild Renal Impairment: A Post Hoc Analysis of Clinical TrialsElizabeth S Ommen, Lei Xu, Edward A O'Neill, et al.
Drugs & Aging|February 11, 2014
Safety of sitagliptin in elderly patients with type 2 diabetes: a pooled analysis of 25 clinical studiesElizabeth M Round, Samuel S Engel, Gregory T Golm, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|June 13, 2013
Assessment of AACE/ACE recommendations for initial dual antihyperglycemic therapy using the fixed-dose combination of sitagliptin and metformin versus metforminSamuel S Engel, Thomas L Seck, Gregory T Golm, et al.
The Journal of Clinical Investigation|June 6, 2007
Adiponectin deficiency increases leukocyte-endothelium interactions via upregulation of endothelial cell adhesion molecules in vivoRaogo Ouedraogo, Yulan Gong, Brett Berzins, et al.
Hepatology Communications|February 7, 2018
Clinical endpoints and adaptive clinical trials in precirrhotic nonalcoholic steatohepatitis: Facilitating development approaches for an emerging epidemicClaudia Filozof, Shein-Chung Chow, Lara Dimick-Santos, et al.
Molecular and Cellular Biology|February 18, 2004
The NAD(P)H oxidase homolog Nox4 modulates insulin-stimulated generation of H2O2 and plays an integral role in insulin signal transductionKalyankar Mahadev, Hiroyuki Motoshima, Xiangdong Wu, et al.
Alternative Therapies in Health and Medicine|September 29, 2007
Mindfulness-based stress reduction is associated with improved glycemic control in type 2 diabetes mellitus: a pilot studySteven Rosenzweig, Diane K Reibel, Jeffrey M Greeson, et al.
Diabetes|May 30, 2006
Adiponectin suppression of high-glucose-induced reactive oxygen species in vascular endothelial cells: evidence for involvement of a cAMP signaling pathwayRaogo Ouedraogo, Xiangdong Wu, Shi-Qiong Xu, et al.
Pageof 8